Oxidation of innate immune checkpoint cd47 on cancer cells with non‐thermal plasma

30Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Non‐thermal plasma (NTP) therapy has been emerging as a promising cancer treatment strategy, and recently, its ability to locally induce immunogenic cancer cell death is being unraveled. We hypothesized that the chemical species produced by NTP reduce immunosuppressive surface proteins and checkpoints that are overexpressed on cancerous cells. Here, 3D in vitro tumor models, an in vivo mouse model, and molecular dynamics simulations are used to investigate the effect of NTP on CD47, a key innate immune checkpoint. CD47 is immediately modulated after NTP treatment and simulations reveal the potential oxidized salt‐bridges responsible for conformational changes. Umbrella sampling simulations of CD47 with its receptor, signal‐regulatory protein alpha (SIRPα), demonstrate that the induced‐conformational changes reduce its binding affinity. Taken together, this work provides new insight into fundamental, chemical NTP‐cancer cell interaction mechanisms and a previously overlooked advantage of present NTP cancer therapy: reducing immunosuppressive signals on the surface of cancer cells.

Cite

CITATION STYLE

APA

Lin, A., Razzokov, J., Verswyvel, H., Privat‐maldonado, A., De Backer, J., Yusupov, M., … Bogaerts, A. (2021). Oxidation of innate immune checkpoint cd47 on cancer cells with non‐thermal plasma. Cancers, 13(3), 1–15. https://doi.org/10.3390/cancers13030579

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free